S100A1, S100 calcium binding protein A1, 6271

N. diseases: 396; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor
0.050 Biomarker disease BEFREE Material from 12 female and 15 male patients (13 granular cell tumours of the sellar region, 10 pituicytomas, four spindle cell oncocytomas) collected in the German Registry of Pituitary Tumours between 1993 and 2015 was re-evaluated according to the current WHO classification of tumours of the central nervous system and supplementary immunohistochemistry including S100-protein, CD56, CD68, thyroid transcription factor-1 (TTF-1), and Ki-67 was performed. 27744503 2017
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor
0.050 Biomarker disease BEFREE The potentially difficult differential diagnosis between chromophobe RCC and oncocytoma may be facilitated by S100A1 and CD82. 21204715 2011
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor
0.050 AlteredExpression disease BEFREE Statistical analyses comparing the different expression of S100A1 in clear cell and chromophobe renal cell carcinomas observed by immunohistochemical and RT-PCR methods showed significant values (P<0.001), such as when comparing by both techniques the different levels of S100A1 expression in chromophobe renal cell carcinomas and oncocytomas (P<0.001). 17483815 2007
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor
0.050 Biomarker disease BEFREE Nine oncocytomas showed strong immunoreactivity for S100A1. 17394501 2007
CUI: C0949541
Disease: Hurthle Cell Tumor
Hurthle Cell Tumor
0.050 AlteredExpression disease BEFREE Fifty-five tissue samples (15 clear cell RCCs, 15 papillary RCCs, 7 chromophobe RCCs, 8 oncocytomas and 10 normal renal tissues) were studied The gene expressions of S100A1 and KIT were analysed by one-step RT-PCR by using the specific primers. 15780567 2005